Abstract
In many hepatic tumors the reduced activities of benzo[a]pyrene (BP) hydroxylase or drug-metabolizing enzymes were observed, when compared to the enzyme activities in normal adult liver, from which hepatic tumor was originated (Adamson and Fouts, 1961). Conney et al. (1957) described the remarkable and now widely recognized induction of BP hydroxylase activity in rat liver by the prior administration of BP itself, or 3-methylcholanthrene (MC), or other polycyclic hydrocarbons. An apparent induction of the drug-metabolizing enzymes by an inducer, such as MC or phenobarbital (PB), was also demonstrated in some lines of “slow-growing” Morris hepatoma (Conney and Burns, 1963; Hart et al., 1965; Watanabe et al., 1970, 1975a, 1975b), but not in Morris hepatoma 7777 (Miyake et al., 1974), Novikoff hepatoma (Hart etal., 1965), and some lines of Yoshida ascites hepatoma (Sugimura et al., 1966), all of which were considered as lines of rapidly growing tumors (Morris,1972). It was then observed that the activity and the inducibility by inducers of the drug-metabolizing enzymes were roughly correlated with the growth rate of the tumor in the host. On the other hand, very low activities of some of the drug-metabolizing enzymes were detected in the liver from newborn and fetal animals, compared with those in the liver from the corresponding adult animals (Hart et al., 1962; Watanabe et al., 1970). The inducibility of BP hydroxylation enzyme sometimes appears to be a determinant factor among those which affect the sensitivity of animals to chemical carcinogens (Watanabe et al., 1975; Nebert et al., 1978).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- BP:
-
Benzo(a)pyrene
- MC:
-
3-Methylcholanthrene
- UT:
-
Untreated
- PB:
-
Phenobarbital
- P-450:
-
Cytochrome P-450
- NADPH-P-450 reductase:
-
NADPH-Cytochrome P-450 (Cytochrome c) reductase
- K-phosphate:
-
Potassium phosphate
References
Adamson, R. H., and Fouts, J. R., 1961, The metabolism of drugs by hepatic tumors, Cancer Res., 21:667.
Conney, A. H., and Burns, J. J., 1963, Induced synthesis of oxidative enzymes in liver microsomes by polycyclic hydrocarbons and drugs, Adv. Enzyme Regulation 1:189.
Conney, A. H., Miller, E. C., and Miller, J. A., 1957, Substrate induced synthesis and other properties of benzpyrene hydroxylase in rat liver, J. Biol. Chem., 228:753.
Domin, B. A., Serabjit-Singh, C. J., Vanderslice, R. R., Devereux, T. R., Fouts, J. R., Bend, J. R., and Philpot, R. M., 1984, Tissue and cellular differences in the expression of cytochrome P-450 isozymes, in: “Proceeding of 9th International Congress of Pharmacology,” W. Paton, J. Mitchell and P. Turner, eds., Vol. 3, p. 219, Macmillan Press, London.
Fennell, P. M., and Strobel, H. V., 1982, Preparation of homogeneous NADPHcytochrome P-450 reductase from rat hepatoma, Biochem. Biophys. Acta 709:173.
Gelboin, H. V., 1969, A microsome-dependent binding of benzo[a]pyrene to DNA, Cancer Res., 29:1272.
Goldstein, J. A., and Linko, P., 1984, Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues, Mol. Pharmacol., 25:185.
Guengerich, F. P., 1978, Separation and purification of multiple forms of microsomal cytochromes P-450. Partial characterization of three apparently homogeneous cytochromes P-450 isolated from liver microsomes of phenobarbital and 3-methylcholanthrene-treated rats, J. Biol. Chem., 253:7931.
Harada, N., and Omura, T., 1981, Selective induction of two different molecular species of cytochrome P-450 by phenobarbital and 3-methylcholanthrene, J. Biochem., 89:237.
Hart, L. G., Adamson, R. H., Dixon, R. C., and Fouts, J. R., 1962, Stimulation of hepatic microsomal drug metabolism in the newborn and fetal rabbit, J. Pharmacol. Exptl. Therap., 137:103.
Hart, L. G., Adamson, R. H., Morris, H. P., and Fouts, J. R., 1965, The stimulation of drug metabolism in various rat hepatomas, J. Pharmacol. Exptl. Therap., 149:7.
Imai, Y., 1976, The use of 8-aminooctyl Sepharose for the separation of some components of the hepatic microsomal electron transfer system, J. Biochem., 80:365.
Kusunose, E., Ogita, K., Ichihara, K., and Kusunose, M., 1981, Effect of cytochrome b5 on fatty acid co-and (w-1)-hydroxylation catalyzed by partially purified cytochrome P-450 from rabbit kidney cortex microsomes, J. Biochem., 90:1069.
Miller, E. C., and Miller, J. A., 1966, Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules, Pharmacol. Rev., 18:805.
Miyake, Y., Gaylor, J. L., and Morris, H. P., 1974, Abnormal microsomal cytochromes and electron transport in Morris hepatoma, J. Biol. Chem., 249:1980.
Morris, H. P., 1972, Isozymes in selected hepatomas and some biological characteristics of a spectrum of transplantable hepatomas, in “Isozymes and Enzyme Regulation in Cancer,” S. Weinhouse, and T. Ono, eds., p. 95, Univ. Tokyo Press, Tokyo.
Nebert, D. W., Atlas, S. A., Guenthner, T. M., and Kouri, R. E., 1978, The Ah locus: genetic regulation of the enzymes which metabolize polycyclic hydrocarbons and the risk for cancer, in: “Polycyclic Hydrocarbons and Cancer,” H. V. Gelboin and P.O.P. Ts’o, eds., Vol. 2, p. 345, Academic Press, New York.
Negishi, M., and Nebert, D. W., 1979, Structural gene products of the “Ah” locus: genetic and inirnunochemical evidence for two forms of mouse liver cytochrome P-450 induced by 3-methylcholanthrene, J. Biol. Chem., 254: 11015.
Ohmachi, T., Sagami, I., Fujii, H., and Watanabe, M., 1985, Microsomal monooxygenase system in Morris hepatoma: purification and characterization of cytochrome P-450 from Morris hepatoma 5123D of 3-methylcholanthrene-treated rats, Arch. Biochem. Biophys., 236:176.
Ryan, D. E., Thomas, P. E., Korzeniowski, D., and Levin, W., 1979, Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene, J. Biol. Chem., 254:1365.
Sagami, I., and Watanabe, M., 1983, Purification and characterization of pulmonary cytochrome P-450 from 3-methylcholanthrene-treated rats, J. Biochem., 93:1499.
Saine, S. E., and Strobel, H. W., 1976, Drug metabolism in liver and tumors. Resolution of components and reconstitution of activity, Mol.Pharmacol., 12:649.
Strobel, H. W., Digman, J. D., Saine, S. E., Fang, W.-F., and Fennell, P. M., 1978, The drug metabolism systems of liver and liver tumors:A comparison of activities and characteristics, Mol. Cell. Biochem., 22:79.
Sugimura, T., Ikeda, K., Hirota, K., Hozumi, M., and Morris, H. P., 1966, Chemical, enzymatic, and cytochrome assays of microsomal fraction of hepatoma with different growth rates, Cancer Res., 26:1711.
Vatsis, K. P., Theoharides, A. D., Kupfer, D., and Coon, M. J., 1982, Hydroxylation of prostaglandins by inducible isozymes of rabbit liver microsomal cytochrome P-450. Participation of cytochrome b5, J. Biol. Chem., 257:11221.
Wada, A., Okamoto, M., Nonaka, Y., and Yamano, T., 1984, Aldosterone biosynthesis by a reconstituted cytochrome P-45011ß system, Biochem. Biophys. Res. Commun., 119:365.
Watanabe, M., Konno, K., and Sato, H., 1975a, Aryl hydrocarbon hydroxylase in Morris hepatoma 5123D, Gann, Jpn. J. Cancer Res., 66:499.
Watanabe, M., Konno, K., and Sato, H., 1975b, Properties of aryl hydrocarbon hydroxylase in microsomes of Morris hepatoma 5123D and the host liver, Gann, Jpn. J. Cancer Res., 66:505.
Watanabe, M., Potter, V. R., and Morris, H. P., 1970, Benzpyrene hydroxylase activity and its induction by methylcholanthrene in Morris hepatomas, in host livers, in adult livers, and in rat liver during development, Cancer Res., 30:263.
Watanabe, M., Sagami, I., Ohmachi, T., and Fujii, H., 1985, Characteristics of purified cytochrome P-450s in microsomes of rat lung and Morris hepatoma 5123D, in: “P-450 and Chemical Carcinogenesis,” Y. Tagashira and T. Omura, eds., p. 19, Plenum Press, New York.
Watanabe, M., Watanabe, K., Konno, K., and Sato, H., 1975, Genetic differences in the induction of aryl hydrocarbon hydroxylase and benzo[a]pyrene carcinogenesis in C3H/He and DBA/2 strains of mice, Gann, Jpn. J. Cancer Res., 66:217.
Weisburger, J. H., and Weisburger, E. K., 1973, Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids, Pharmacol. Rev., 25:1.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Watanabe, M., Ohmachi, T., Sagami, I. (1986). Multiplicity of Cytochrome P-450 in Morris Hepatoma. In: Kocsis, J.J., Jollow, D.J., Witmer, C.M., Nelson, J.O., Snyder, R. (eds) Biological Reactive Intermediates III. Advances in Experimental Medicine and Biology, vol 197. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5134-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5134-4_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5136-8
Online ISBN: 978-1-4684-5134-4
eBook Packages: Springer Book Archive